FindTrial
Sign In

The effect of drug treatment on serum irisin and its association with endothelial function

The effect of drug treatment on serum irisin and its association with endothelial function

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15005844
Enrollment
Unknown
Registered
2015-01-15
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

Type 2 Diabetes mellitus group:Nil
Normal group:Nil

Sponsors

Dongguan Pepole's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: 15 newly diagnosed type 2 diabetic patients were selected and 15 healthy subjects were selected as controls.

Exclusion criteria

Exclusion criteria: Obese (BMI more than 30 kg/m2) subjects, smokers, malignant neoplasms or liver diseases, renal failure(serum creatinine more than at least 176umol/L), or endocrinological disease other than diabetes mellitus were also excluded from the study. In addition, no patient was taking any drugs, such as thyroxine, oestrogen supplements, diuretics, antihypertensive drugs or ß-blockers or lipid-lowering drugs.

Design outcomes

Primary

MeasureTime frame
endothelial function;Serum Irisin concentration;—

Contacts

Public ContactWang Haohua
hello_vanwang@sina.com+86 13728188332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026